Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.
about
Future perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynxRole of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcusProteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model.Interleukin-17A mediates acquired immunity to pneumococcal colonizationStreptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression.Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine.Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.A modified Janus cassette (Sweet Janus) to improve allelic replacement efficiency by high-stringency negative selection in Streptococcus pneumoniae.Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumoniaT(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.Current advances and challenges in the development of Acinetobacter vaccines.Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae.Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage.Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in miceDifferential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensisMucosal vaccination against bacterial respiratory infections.Rationale and prospects for novel pneumococcal vaccines.Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion proteinTissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.Correlates of vaccine protection from influenza and its complications.Th17 cell based vaccines in mucosal immunity.Immune ageing and susceptibility to Streptococcus pneumoniae.Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.Interluekin-17A (IL17A).Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.Density, Serotype Diversity, and Fitness of Streptococcus pneumoniae in Upper Respiratory Tract Cocolonization With Nontypeable Haemophilus influenzaeImpaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.IL-17 signalling restructures the nasal microbiome and drives dynamic changes following Streptococcus pneumoniae colonization.Distinct Cellular Pathways for Induction of CD4+ T Cell-Dependent Antibody Responses to Antigen Expressed by Intact Bacteria Versus Isolated Soluble Antigen.Evaluation of the role of stat3 in antibody and TH17-mediated responses to pneumococcal immunization and infection using a mouse model of Autosomal Dominant Hyper IgE Syndrome.
P2860
Q26863174-44E4D345-F1DB-4579-A2A6-87469D08A6CEQ27026700-BC416B2E-9F96-401B-AD80-47EC21ADBC4BQ30208978-8B38C5F6-1961-4EBA-AFC0-ED319EDFBD61Q33370537-C4467A90-03E5-4EAE-85BC-8CAB68B0C517Q33497638-38A45A84-90B0-484B-BD90-C6ABD2F1F2D0Q33909187-4BA84293-6DCD-4511-A8C5-CAF9482FC12BQ33963100-AF1DE0B9-46F7-4F45-BB22-54AB3EE59267Q34020348-D6A106CF-2A02-4DA1-B302-A9447C9A7C49Q34229627-D6EB20EF-FC7D-475E-A14F-286CD19B05CEQ34298079-F84F270A-F76B-417B-A80F-EE09077BC90DQ34649770-F82D3384-325D-42DD-B4A1-8060AF647E90Q35181636-7595974C-ECB1-42F3-931A-429EE207F9CAQ35193822-4AE8F34F-A0ED-4205-A985-0BD0D4878552Q35665351-B84754CE-B765-4E20-B033-C63E1E4B185AQ35745680-C4070DBD-6ACC-4BA6-9D70-5D15D3F63EB4Q35902005-13E7D3B1-6DDF-49D6-81F3-4A9499C36E3AQ36256352-4B852EFF-052C-421C-8844-055DC53ED79EQ36384449-8E1C30B0-BA28-4A03-AD01-904BE9B74061Q36605149-84D3BBDB-03D4-49C8-B30B-6CCE5B234EC2Q36816582-5710955E-E2C6-4C8B-8F6C-8890A1BDB508Q37190966-563E6FB3-2474-4C06-A1C0-E53AEFE849A6Q37241352-F13C8D7C-3709-42FD-96DB-BCC1907CAF20Q37289261-DCB5F564-8DCC-4A6F-A7B1-9EF6D465F1CFQ37290114-B189991F-02EE-4851-88FB-514F9DBA43DDQ37309218-33E4989A-B65A-462F-9C28-067CBF60EB0DQ37635127-BFA63D9A-7DA6-43DE-A513-F4DC69DDCFB1Q37656365-97059060-8E05-49FC-A3E4-502B6B977EB4Q37683238-B3DFEDDA-F28B-42FC-BC1B-70C89F06DAB6Q37713348-05AA3AFD-47FE-41A2-896E-E262B3871A30Q37976539-5C11DCCB-0D2B-416C-970D-2B08D9902275Q38106558-3C886BD7-1ADF-4979-A4C2-9E7782B2DB22Q38608479-CF4EF8B2-DF56-4235-B88C-3930768D5CABQ38668300-A1AE6C71-2554-40EC-A709-C9B9F8E0E2FEQ39103136-04140A99-CD13-4709-B2A3-569EC6CC1D54Q39147459-0D56CFED-69E2-427D-AEA6-703D389C764DQ40570250-4B4B916F-C1E6-4643-B21F-2AA80FA6C795Q42171376-68652500-018E-4778-8FD1-395A0BC7D32FQ42654482-264CF460-40AE-4234-B562-B4A5F736357AQ45813817-74A00BF1-4D6F-4750-B3A4-2ABBF4A0E50CQ49791367-F8CD05A7-7A5F-458C-8A98-FCD6335473DB
P2860
Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@ast
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@en
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@nl
type
label
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@ast
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@en
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@nl
prefLabel
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@ast
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@en
Protection against nasopharyng ...... antigen-specific CD4+ T cells.
@nl
P2093
P2860
P356
P1476
Protection against nasopharyng ...... antigen-specific CD4+ T cells
@en
P2093
Alan Basset
Amit Srivastava
Claudette M Thompson
Richard Malley
P2860
P304
P356
10.1128/IAI.00141-08
P407
P577
2008-04-07T00:00:00Z